- Home
- NAGE vs SABR Comparison
NAGE vs SABR Comparison
Compare NAGE & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAGE | SABR |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.6M | 489.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAGE | SABR |
|---|---|---|
| Price | $4.93 | $1.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $16.33 | $4.15 |
| AVG Volume (30 Days) | 732.8K | ★ 9.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.37 | $6.79 |
| Revenue Next Year | $20.36 | $3.14 |
| P/E Ratio | $21.29 | ★ $0.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.93 | $0.90 |
| 52 Week High | $14.66 | $4.63 |
Technical Indicators
Market Signals| Indicator | NAGE | SABR |
|---|---|---|
| Relative Strength Index (RSI) | 26.98 | 43.69 |
| Support Level | $4.93 | $0.91 |
| Resistance Level | $5.32 | $1.32 |
| Average True Range (ATR) | 0.26 | 0.12 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 5.60 | 40.71 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company sold its growing hotel IT solutions division (9% of revenue) to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.